Back to mobile site

TD Cowen on Astrana Health, Inc (ASTH): 'Execution on Track, Structural Differentiation Reinforced'

April 16, 2026 8:57 AM EDT Send to a Friend
TD Cowen analyst Jailendra Singh reiterated a Buy rating and $38.00 price target on Astrana Health, Inc (NASDAQ: ASTH).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login